KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026)

Amneal Pharmaceuticals has reported Exchange Rate Effect over the past 9 years, most recently at -$209000.0 for Q4 2025.

For Q4 2025, Exchange Rate Effect rose 71.76% year-over-year to -$209000.0; the TTM value through Dec 2025 reached -$1.7 million, down 68.17%, while the annual FY2025 figure was -$1.7 million, 68.17% down from the prior year.
Exchange Rate Effect for Q4 2025 was -$209000.0 at Amneal Pharmaceuticals, up from -$694000.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at $767000.0 in Q1 2023 and troughed at -$3.7 million in Q4 2022.
A 5-year average of -$409750.0 and a median of -$255000.0 in 2023 define the central range for Exchange Rate Effect.
Biggest five-year swings in Exchange Rate Effect: surged 148.79% in 2023 and later tumbled 10014.29% in 2025.
Year by year, Exchange Rate Effect stood at $178000.0 in 2021, then plummeted by 2200.56% to -$3.7 million in 2022, then soared by 105.38% to $201000.0 in 2023, then plummeted by 468.16% to -$740000.0 in 2024, then surged by 71.76% to -$209000.0 in 2025.
Business Quant data shows Exchange Rate Effect for AMRX at -$209000.0 in Q4 2025, -$694000.0 in Q3 2025, and -$307000.0 in Q2 2025.